Tejara Capital LTD Silverback Therapeutics, Inc. Transaction History

Tejara Capital LTD

  • $275 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
N/A
-30,000 Reduced 28.92%
73,739 $404 Million
Q3 2023

Nov 13, 2023
SELL
N/A
-29,782 Reduced 22.31%
103,739 $392 Million
Q2 2023

Aug 11, 2023
SELL
N/A
-74,034 Reduced 35.67%
133,521 $895 Million
Q1 2023

May 12, 2023
BUY
N/A
172,800 Added 497.19%
207,555 $1.35 Billion
Q4 2022

Feb 13, 2023
BUY
$0.0 - $6.07 $0 - $210,962
34,755 New
34,755 $296 Million

Others Institutions Holding SBTX

# of Institutions
122
Shares Held
61.4M
Call Options Held
1.37M
Put Options Held
83.8K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email